Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback